Antisera towards the bioactive peptides, neurotensin (NT, 13 residues)
and neuromedin N (NMN, 6 residues), as well as towards three regions
of their 147-residue canine precursor were used to identify and to qua
ntitate precursor-derived peptides in extracts of human BON cells. Thi
s cell-line, which was obtained from a human pancreatic carcinoid tumo
r, constituitively expresses NT/NMN mRNA and secretes NT. Quantitation
of seven precursor-derived peptides led us to conclude that BON cells
display the intestinal pattern of NT/NMN precursor processing, which
is primarily characterized by the production of a large molecular (125
amino acid) form of NMN. Four large molecular components, identified
by immunochemical analyses and Western blotting, displayed physico-che
mical properties which, for the most part, were consistent with the st
ructures predicted from the partially-known human mRNA sequence. Howev
er, as shown previously for these peptides in canine gut, the empirica
lly determined M(r) and pI values were slightly higher than those pred
icted solely from the amino acid content, perhaps due to the presence
of additional substituents. These results suggest that BON cells may p
rovide a good in vitro model in which to study the regulation of intes
tinal NT/NMN precursor processing and the nature of the enzyme(s) invo
lved.